Stock comparison
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($196.28 B vs $167.49 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($196.28 B vs $167.49 B).
Market value leader
AMGN
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($196.28 B vs $167.49 B).
Revenue leader
AMGN
AMGN: $36.75B vs GILD: $29.44B.
Profit leader
GILD
AMGN: $7.71B vs GILD: $8.51B.
Margin leader
GILD
AMGN: 21.0% vs GILD: 28.9% net margin.
| Metric | AMGN | GILD |
|---|---|---|
| Market cap | $196.28 B | $167.49 B |
| US-listed rank | #75 | #92 |
| Revenue (latest FY) | $36.75B | $29.44B |
| Net income (latest FY) | $7.71B | $8.51B |
| Net margin | 21.0% | 28.9% |
| P/E (trailing FY) | 25.5x | 19.7x |
| SEC filings | 1,011 | 968 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($196.28 B vs $167.49 B).
In their latest fiscal years, AMGEN INC reported $36.75B in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: AMGEN INC and GILEAD SCIENCES, INC., or browse the full rankings.